ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,068,448 | -12.9% | 18,241,284 | -1.4% | 0.45% | -6.4% |
| Q2 2023 | $568,708,076 | -16.6% | 18,500,588 | -2.2% | 0.48% | -21.5% |
| Q1 2023 | $681,642,562 | +0.8% | 18,918,750 | +10.5% | 0.62% | -12.8% |
| Q4 2022 | $676,554,025 | -5.8% | 17,119,282 | -4.2% | 0.70% | -4.7% |
| Q3 2022 | $717,943,000 | -5.1% | 17,868,175 | -0.7% | 0.74% | -4.6% |
| Q2 2022 | $756,506,000 | +1622.9% | 17,994,918 | +1496.7% | 0.78% | +2403.2% |
| Q1 2022 | $43,909,000 | – | 1,127,031 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |